|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fenamiphos | CAS 22224-92-6 | ||
| C13H22NO3PS | RTECS TB3675000 | ||
|
Synonyms & Trade Names Ethyl 3-methyl-4-(methylthio)phenyl-(1-methylethyl)phosphoramidate, Nemacur®, Phenamiphos |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 0.1 mg/m3 [skin] | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion | ||
|
Physical Description Off-white to tan, waxy solid. [insecticide] [Note: Found commercially as a granular ingredient (5-15%) or in an emulsifiable concentrate (400 g/l).] |
|||
|
MW: 303.4 |
BP: ? |
MLT: 121°F |
Sol: 0.03% |
|
VP: 0.00005 mmHg |
IP: ? |
|
Sp.Gr: 1.14 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities None reported [Note: May hydrolyze under alkaline conditions.] |
|||
|
Measurement Methods NIOSH 5600 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty) | |
|
Target Organs
respiratory system, central nervous system, cardiovascular system, blood cholinesterase |
|
| See also: INTRODUCTION |